TERESA POSADAS: Open Payments
NPI 1326610585 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$907 in 25 payments from 14 companies in 2025. Trend: 2023 $701 · 2024 $388 · 2025 $907
Food & beverage: $849Education: $59
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 5 | $262 |
| Incyte Corporation | 2 | $147 |
| Ionis Pharmaceuticals, Inc. | 2 | $137 |
| CSL Behring | 3 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $61 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| Grifols USA, LLC | 2 | $40 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $27 |
| Pharming Healthcare, Inc. | 1 | $25 |
| Genentech USA, Inc. | 1 | $22 |
Products named: DUPIXENT, Opzelura, DAWNZERA, TAKHZYRO, Andembry, Xembify, NEFFY, RUCONEST.
Industry payments across FL — which companies pay providers there.
